Florida Consumer News
SEE OTHER BRANDS

Hottest consumer products news from Florida

Florida Consumer News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Consumer News.

Press releases published on September 7, 2025

Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 - UNCY

Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 - UNCY

Faruqi …

Faruqi & Faruqi Reminds SelectQuote Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 10, 2025 - SLQT

Faruqi & Faruqi Reminds SelectQuote Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 10, 2025 - SLQT

Faruqi …

Faruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANRO

Faruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 - ANRO

Faruqi …

KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of KBR, Inc. (NYSE: KBR) resulting from allegations that KBR may have issued …

Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST

Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST

Faruqi …

Faruqi & Faruqi Reminds PubMatic Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 20, 2025 - PUBM

Faruqi & Faruqi Reminds PubMatic Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 20, 2025 - PUBM

Faruqi …

Faruqi & Faruqi Reminds Flywire Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2025 - FLYW

Faruqi & Faruqi Reminds Flywire Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2025 - FLYW

Faruqi …

Faruqi & Faruqi Reminds Semler Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR

Faruqi & Faruqi Reminds Semler Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR

Faruqi …

Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT

Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT

Faruqi …

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting from allegations …

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

Faruqi …

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 - IRBT

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 - IRBT

Faruqi …

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ: …

HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres

HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres

BERLIN, Sept. 07, 2025 (GLOBE NEWSWIRE) -- HKC Group, a global display manufacturer, makes its European debut at IFA 2025 with a coordinated showcase across its three brands—HKC, KOORUI, and ANTGAMER—each unveiling a breakthrough product. The move …

Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing

Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing

Salt Lake City, Sept. 06, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only and does not provide medical advice. Some links in this article may be promotional affiliate links. If readers click on these links and complete a …

Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands

Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands

New York, Sept. 06, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions